APA (7th ed.) Citation

Duan, Z., Gao, Y., Huang, M., Liang, Y., Hao, J., Wang, J., & Cai, G. (2026). Protocol for Developing and Validating a Multimarker-Clinical Prediction Model of SGLT2 Inhibitor-Induced Acute eGFR Dip in CKD Stages 3–4: A Three-Stage Urinary Proteomics Study. Life (2075-1729), 16(6), 865. https://doi.org/10.3390/life16060865

Chicago Style (17th ed.) Citation

Duan, Zhiyu, Youhe Gao, Mengjie Huang, Yanjun Liang, Jing Hao, Jie Wang, and Guangyan Cai. "Protocol for Developing and Validating a Multimarker-Clinical Prediction Model of SGLT2 Inhibitor-Induced Acute EGFR Dip in CKD Stages 3–4: A Three-Stage Urinary Proteomics Study." Life (2075-1729) 16, no. 6 (2026): 865. https://doi.org/10.3390/life16060865.

MLA (9th ed.) Citation

Duan, Zhiyu, et al. "Protocol for Developing and Validating a Multimarker-Clinical Prediction Model of SGLT2 Inhibitor-Induced Acute EGFR Dip in CKD Stages 3–4: A Three-Stage Urinary Proteomics Study." Life (2075-1729), vol. 16, no. 6, 2026, p. 865, https://doi.org/10.3390/life16060865.